Search Results - John Mancini

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Reframing the Paradigm for Assessing Optimal Test Selection When Suspecting Chronic Coronary Disease by G. B. John Mancini

    Get full text
    Article


  2. 2

    Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic revie... by Arveen Shokravi, Jayant Seth, G. B. John Mancini

    Published in Cardiovascular Diabetology (2025-09-01)
    Get full text
    Article


  3. 3

    Adoption of the PREVENT (Predicting Risk of Cardiovascular Disease EVENTs) Risk Algorithm by G.B.John Mancini, MD, Arnold Ryomoto, BSc

    Published in JACC: Advances (2024-08-01)
    Get full text
    Article


  4. 4

    Erratum: Leiter et al. Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease. Reviews in Cardiovascular Medic... by Lawrence A. Leiter, Robert A. Hegele, Vivien Brown, Jean Bergeron, Erin S. Mackinnon, G. B. John Mancini

    Published in Reviews in Cardiovascular Medicine (2024-10-01)
    Get full text
    Article


  5. 5

    Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease by Lawrence A. Leiter, Robert A. Hegele, Vivien Brown, Jean Bergeron, Erin S. Mackinnon, G. B. John Mancini

    Published in Reviews in Cardiovascular Medicine (2024-05-01)
    Get full text
    Article


  6. 6

    Physician‐Reported Facilitators and Barriers for Side Effect Management of Heart Failure Medications by Sabrina Mangal, Maryam Hyder, John Mancini, Kate Zarzuela, William McDonald, Monika Safford, Mark Lachs, Parag Goyal

    Get full text
    Article


  7. 7

    Epidemiology and treatment of heart failure with chronic obstructive pulmonary disease in Canadian primary care by Nathaniel M. Hawkins, Sandra Peterson, Samaneh Salimian, Catherine Demers, Karim Keshavjee, Sean A. Virani, G.B. John Mancini, Sabrina T. Wong

    Published in ESC Heart Failure (2023-12-01)
    Get full text
    Article


  8. 8

    The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis by Muhammad Usman Ali, G. B. John Mancini, Donna Fitzpatrick-Lewis, Kim A. Connelly, Eileen O’Meara, Shelley Zieroth, Diana Sherifali

    Published in Cardiovascular Diabetology (2024-02-01)
    Get full text
    Article


  9. 9

    Consideration and Application of Lipoprotein(a) in the Risk Assessment of Atherosclerotic Cardiovascular Disease Risk in Adults by Tiffany Yuen, MD, FRCPC, G.B. John Mancini, MD, FRCPC, FACP, FACC, Robert A. Hegele, MD, FRCPC, Glen J. Pearson, PharmD, FCCS

    Published in CJC Open (2024-03-01)
    Get full text
    Article


  10. 10

    Cardiovascular risk and subclinical atherosclerosis in first-degree relatives of patients with premature cardiovascular disease by Diana N. Vikulova, Danielle Pinheiro-Muller, Gordon Francis, Frank Halperin, Tara Sedlak, Keith Walley, Christopher Fordyce, GB John Mancini, Simon N. Pimstone, Liam R. Brunham

    Published in American Journal of Preventive Cardiology (2024-09-01)
    Get full text
    Article


  11. 11

    Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study by Milan Gupta, Rajvi J. Wani, Khalid Al Faraidy, Jean Bergeron, Eduardo Contreras, Angel Alberto Garcia Peña, G. B. John Mancini, Francisco Padilla, Abel Alberto Pavia Lopez, Kiran Philip, Johnny Wu, Erin S. Mackinnon

    Published in Cardiology and Therapy (2023-10-01)
    Get full text
    Article


  12. 12

    Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial by Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S. Bajaj, G. B. John Mancini, Norman C. Wong, April Slee, Fernando G. Ang, Wally Rapattoni, Brendon L. Neuen, Clare Arnott, Vlado Perkovic, Kenneth W. Mahaffey

    Get full text
    Article


  13. 13

    Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label condi... by Peter E. Penson, G. B. John Mancini, Peter P. Toth, Seth S. Martin, Gerald F. Watts, Amirhossein Sahebkar, Dimitri P. Mikhailidis, Maciej Banach, on behalf of Lipid and Blood Pressure Meta‐Analysis Collaboration (LBPMC) Group & International Lipid Expert Panel (ILEP)

    Published in Journal of Cachexia, Sarcopenia and Muscle (2018-12-01)
    Get full text
    Article


  14. 14

    Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)... by Peter E. Penson, Eric Bruckert, David Marais, Željko Reiner, Matteo Pirro, Amirhossein Sahebkar, Gani Bajraktari, Erkin Mirrakhimov, Manfredi Rizzo, Dimitri P. Mikhailidis, Alexandros Sachinidis, Dan Gaita, Gustavs Latkovskis, Mohsen Mazidi, Peter P. Toth, Daniel Pella, Fahad Alnouri, Arman Postadzhiyan, Hung‐I Yeh, G.B. John Mancini, Stephan vonHaehling, Maciej Banach, International Lipid Expert Panel (ILEP)

    Published in Journal of Cachexia, Sarcopenia and Muscle (2022-06-01)
    Get full text
    Article


  15. 15

    Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP) by Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, Niki Katsiki, Dimitri P. Mikhailidis, Peter P. Toth, Ioanna Gouni-Berthold, John Mancini, David Marais, Patrick Moriarty, Massimiliano Ruscica, Amirhossein Sahebkar, Dragos Vinereanu, Arrigo Francesco Giuseppe Cicero, Maciej Banach, Julio Acosta, Mutaz Al-Khnifsawi, Fahad Alnouri, Fahma Amar, Atanas G. Atanasov, Gani Bajraktari, Maciej Banach, Ioanna Gouni-Berthold, Sonu Bhaskar, Agata Bielecka-Dąbrowa, Bojko Bjelakovic, Eric Bruckert, Ibadete Bytyçi, Alberto Cafferata, Richard Ceska, Arrigo F.G. Cicero, Krzysztof Chlebus, Xavier Collet, Magdalena Daccord, Olivier Descamps, Dragan Djuric, Ronen Durst, Marat V. Ezhov, Zlatko Fras, Dan Gaita, Ioanna Gouni-Berthold, Adrian V. Hernandez, Steven R. Jones, Jacek Jozwiak, Nona Kakauridze, Amani Kallel, Niki Katsiki, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martinez, Mohsen Mazidi, Dimitri P. Mikhailidis, Erkin Mirrakhimov, Andre R. Miserez, Olena Mitchenko, Natalya P. Mitkovskaya, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Peter E. Penson, Zaneta Petrulioniene, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Dina Radenkovic, Michał Rakowski, Jemaa Riadh, Dimitri Richter, Manfredi Rizzo, Massimiliano Ruscica, Amirhossein Sahebkar, Maria-Corina Serban, Abdullah M.A Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Peter P. Toth, Margus Viigimaa, Pedro Valdivielso, Dragos Vinereanu, Branislav Vohnout, Stephan von Haehling, Michal Vrablik, Nathan D. Wong, Hung-I Yeh, Jiang Zhisheng, Andreas Zirlik

    Published in Pharmacological Research (2023-03-01)
    Get full text
    Article


  16. 16

    Chest Pain Evaluation: Diagnostic Testing by Benjamin J.W. Chow, MD, PhD, FRCPC, FACC, FESC, FASNC, MSCCT, Paul Galiwango, MD, FRCPC, Anthony Poulin, MD, Paolo Raggi, MD, FACC, FAHA, FACP, FASNC, FSCCT, Gary Small, MBChB, PhD, MRCP, Daniel Juneau, MD, FRCPC, Mustapha Kazmi, MD, FRCPC, Bilal Ayach, MC, MSc, PhD, FRCPC, Rob S. Beanlands, MD, FRCPC, Anthony J. Sanfilippo, MD, FRCPC, FACC, Chi-Ming Chow, MDCM, MSc, FRCPC, FCCS, D. Ian Paterson, MD, FRCPC, Michael Chetrit, MD, FRCPC, FACC, Davinder S. Jassal, MD, FACC, FCCS, FRCPC, Kim Connelly, MBBS, PhD, FSCMR, FCCS, Eric Larose, DVM, MD, FRCPC, FCCS, FAHA, Helen Bishop, MD, FRCPC, Malek Kass, MD, Todd J. Anderson, MD, Haissam Haddad, MD, John Mancini, MD, FRCPC, FACP, FACC, Katie Doucet, MD, FRCPR, Jean-Sebastien Daigle, MD, FRCPC, Amir Ahmadi, MD, FRCPC, FACC, FSCCT, Jonathan Leipsic, MD, FRCPC, Siok Ping Lim, MRCP(UK), FRCR(UK), FRCPC, Andrew McRae, MD, PhD, FRCPC, Annie Y. Chou, MD, FRCPC

    Published in CJC Open (2023-12-01)
    Get full text
    Article


Search Tools: